These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23183095)

  • 1. Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice.
    Wang XY; Yao X; Wan YM; Wang B; Xu JQ; Wen YM
    Immunol Lett; 2013 Jan; 149(1-2):88-92. PubMed ID: 23183095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.
    Xu DZ; Wang XY; Shen XL; Gong GZ; Ren H; Guo LM; Sun AM; Xu M; Li LJ; Guo XH; Zhen Z; Wang HF; Gong HY; Xu C; Jiang N; Pan C; Gong ZJ; Zhang JM; Shang J; Xu J; Xie Q; Wu TF; Huang WX; Li YG; Xu J; Yuan ZH; Wang B; Zhao K; Wen YM;
    J Hepatol; 2013 Sep; 59(3):450-6. PubMed ID: 23669281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients.
    Zhou C; Li C; Gong GZ; Wang S; Zhang JM; Xu DZ; Guo LM; Ren H; Xu M; Xie Q; Pan C; Xu J; Hu Z; Geng S; Zhou X; Wang X; Zhou X; Mi H; Zhao G; Yu W; Wen YM; Huang L; Wang XY; Wang B
    Hum Vaccin Immunother; 2017 Sep; 13(9):1989-1996. PubMed ID: 28665747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
    J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
    Moon SH; Shin EC; Noh YW; Lim YT
    Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
    Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanogram doses of alum-adjuvanted HBs antigen induce humoral immune response in mice when orally administered.
    Kapusta J; Pniewski T; Wojciechowicz J; Bociag P; Płucienniczak A
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):143-51. PubMed ID: 20165988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination.
    Zhang W; Du X; Zhao G; Jin H; Kang Y; Xiao C; Liu M; Wang B
    Vaccine; 2009 Aug; 27(36):4938-46. PubMed ID: 19549606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses.
    Mirzaee M; Haghighat S; Golkaran B; Asgarhalvaei F; Mirzaee R; Taghizadeh M; Savoji MA; Esfandiari B; Mahdavi M
    Biomed Environ Sci; 2022 Sep; 35(9):792-803. PubMed ID: 36189994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum.
    Kim SH; Park SA; Kim HK; Cho YJ; Kim KS; Kim YH; Chun JH; Lee NG
    Arch Pharm Res; 2008 Nov; 31(11):1385-92. PubMed ID: 19023533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
    Janssen RS; Mangoo-Karim R; Pergola PE; Girndt M; Namini H; Rahman S; Bennett SR; Heyward WL; Martin JT
    Vaccine; 2013 Nov; 31(46):5306-13. PubMed ID: 23727422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines.
    Wu Y; Li S; Li H; Zhao C; Ma H; Zhao X; Wu J; Liu K; Shan J; Wang Y
    Int J Biol Macromol; 2016 Oct; 91():248-57. PubMed ID: 27185068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
    Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.